These results suggest that the C1772T polymorphism in @GENE$ is not involved in progression or metastasis of @DISEASE$.	1
In our setting, @DISEASE$ among alcoholic individuals seems to be independent of the presence of mutations C282Y, H63D and S65C in the @GENE$ gene.	1
MPO genotype GG is associated with @DISEASE$ in patients with hereditary @GENE$.	1
These three studies do not provide consistent evidence supporting the hypothesis that @GENE$ mutations are associated with an increased risk of @DISEASE$ and with the development of arteriosclerosis.	1
Our prospective findings suggest that individuals carrying the @GENE$ C282Y mutation may be at increased risk of @DISEASE$.	1
We conclude that  homozygosity for the G1514-->A mutation is exclusively responsible for the adult form of @DISEASE$ in this family, and that the A619-->G substitution is not a deleterious mutation but rather a common @GENE$ polymorphism.	1
The data suggest that the @GENE$ gene or a linked locus significantly modulates the risk for @DISEASE$.	1
The novel gene @GENE$ may be related with the infiltration and proliferation of @DISEASE$.	1
Our findings suggest that the genetic variants of the @GENE$ but not the TIM-3 gene contribute to @DISEASE$ susceptibility in this African-American population.	1
In conclusion, the M416V polymorphism of @GENE$ gene is not associated with insulin resistance in @DISEASE$.	1
We found no evidence that mutation in @GENE$,GNGT1,or RGS9 gene is a cause of @DISEASE$.	1
These results suggest that the @GENE$ null genotype may be associated with increased risk of @DISEASE$.	1
These findings suggest that the GSTA1 and @GENE$ polymorphisms are associated with @DISEASE$ susceptibility, especially among smokers.	1
These findings suggest that individual susceptibility to @DISEASE$ may be modulated by GSTM1, @GENE$ and NAT2 polymorphisms.	1
These results suggest that the @GENE$ null-genotype is associated with an increased risk of @DISEASE$, especially in younger individuals.	1
These results support previous reports that the GSTM1 null genotype is associated with a modest increase in risk for @DISEASE$, particularly among heavy smokers, suggest no role for @GENE$ and the need for further study of GSTP1.	1
We conclude that  the two polymorphisms, @GENE$ null and PON1 BB, are common genetic traits that pose low individual risk but may be important determinants of overall population @DISEASE$ risk, particularly among groups exposed to NHL-related carcinogens.	1
We conclude that  the two polymorphisms, @GENE$ null and PON1 BB, are common genetic traits that pose low individual risk but may be important determinants of overall population NHL risk, particularly among groups exposed to @DISEASE$-related carcinogens.	1
Polymorphisms in the oxidative stress-related genes (CYP1A1, GSTM1, @GENE$, MPO, MnSOD) do not seem to be risk factors for @DISEASE$.	1
The @GENE$-null genotype may increase the risk for @DISEASE$ and is associated with favorable prognostic factors, and the presence of at least one GST deletion indicates an improved disease-free survival.	1
This study suggests that certain null GSTM1 and @GENE$ genotypes may be associated with an elevated risk of @DISEASE$ which may be modified by interaction of the two genetic polymorphisms and cigarette smoking.	1
Individuals who bear @GENE$ 0/0 genotype or GSTT1 0/0-GSTM1 0/0 combined genotypes are more susceptible to @DISEASE$, especially for male and younger carriers.	1
Individuals who bear GSTT1 0/0 genotype or @GENE$ 0/0-GSTM1 0/0 combined genotypes are more susceptible to @DISEASE$, especially for male and younger carriers.	1
The gene polymorphism for @GENE$ was not associated with susceptibility to @DISEASE$ in the Chinese population.	1
The genetic polymorphism in @GENE$ gene exon5 was not associated with the susceptibility to @DISEASE$ in northern Chinese population of Han nationality.	1
Polymorphisms in the oxidative stress-related genes (CYP1A1, @GENE$, GSTT1, MPO, MnSOD) do not seem to be risk factors for @DISEASE$.	1
There is a synergy of susceptible genotypes @GENE$ 0/0 and CYP1A1 Val/Val or CYP1A1 Ile/Val to enhance the individual susceptibility to @DISEASE$.	1
These data suggest that polymorphisms in CYP1A1 and @GENE$ contribute to the increased risk of females for @DISEASE$.	1
The combination of @GENE$ genotype 0/0 and matrix metalloproteinase 9 mutant allele (-15621) is a risk factor for @DISEASE$ (OR-7.7).	1
These results support previous reports that the @GENE$ null genotype is associated with a modest increase in risk for @DISEASE$, particularly among heavy smokers, suggest no role for GSTT1 and the need for further study of GSTP1.	1
The present study suggests that the @GENE$ polymorphism may be associated with increased risk of development of @DISEASE$.	1
The results suggest that the @GENE$ null genotype is a risk factor for development of @DISEASE$ among Indian tobacco habitues.	1
Individuals who bear GSTT1 0/0 genotype or GSTT1 0/0-@GENE$ 0/0 combined genotypes are more susceptible to @DISEASE$, especially for male and younger carriers.	1
Our results through Meta-analysis did not support the association between @GENE$ null genotype and @DISEASE$, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of esophageal cancer.	1
Our results through Meta-analysis did not support the association between @GENE$ null genotype and esophageal cancer, but the smokers carring the GSTM1 null genotype might be associated with the increased risk of @DISEASE$.	1
Our results through Meta-analysis did not support the association between GSTM1 null genotype and @DISEASE$, but the smokers carring the @GENE$ null genotype might be associated with the increased risk of esophageal cancer.	1
Our results through Meta-analysis did not support the association between GSTM1 null genotype and esophageal cancer, but the smokers carring the @GENE$ null genotype might be associated with the increased risk of @DISEASE$.	1
No associations between the @GENE$ alleles, including the null allele, and @DISEASE$ were detected in this study.	1
These findings suggest that the @GENE$ and GSTT1 polymorphisms are associated with @DISEASE$ susceptibility, especially among smokers.	1
Because our samples provided quite high power, these results indicate that @GENE$ may not play a major role in Japanese @DISEASE$.	1
We conclude that  at least one susceptibility locus for @DISEASE$ is located within the @GENE$ region in Japanese.	1
Our results partially support the previous studies in other ethnic groups and indicate that the @GENE$ gene may play an important role in the etiology of @DISEASE$ in the Han Chinese.	1
These data suggest that polymorphisms in the @GENE$ gene may be useful as predictors of negative symptom improvement in persons with @DISEASE$ treated with olanzapine.	1
Our data indicate that at least one susceptibility locus for @DISEASE$ is situated within or very close to the @GENE$ region in the Japanese patients.	1
Examination of our own data and those of other groups leads us to conclude that at present, @GENE$ should not be viewed as a gene for which there is replicated evidence for association with @DISEASE$.	1
These findings suggest that the combined effects of the polymorphisms in the GRIN1 and @GENE$ genes might be involved in the etiology of @DISEASE$.	1
These findings suggest that the combined effects of the polymorphisms in the @GENE$ and GRIN2B genes might be involved in the etiology of @DISEASE$.	1
The association reported in this study suggests that the @GENE$ gene is a good candidate for the susceptibility to @DISEASE$.	1
Results indicate that genomic variations of the @GENE$ gene are not likely to be involved substantially in the etiology of @DISEASE$.	1
revealed no significant association between @DISEASE$ and the SNPs in the upstream region of @GENE$, these SNPs apparently do not play a critical role in the pathogenesis of schizophrenia in the Japanese population.	1
revealed no significant association between schizophrenia and the SNPs in the upstream region of @GENE$, these SNPs apparently do not play a critical role in the pathogenesis of @DISEASE$ in the Japanese population.	1
The association reported in this study suggests that the @GENE$ gene is a good candidate for the susceptibility to @DISEASE$.	1
We conclude that  @GENE$ does not play a major role in the pathogenesis of @DISEASE$ in the Japanese population.	1
We conclude that  @GENE$ does not play a major role in the pathogenesis of @DISEASE$ in the Japanese population.	1
We conclude that  @GENE$ does not play a major role in @DISEASE$ pathogenesis in the Japanese population.	1
We conclude that  @GENE$ does not play a major role in @DISEASE$ pathogenesis in the Japanese population.	1
Our results suggest that the three SNPs of @GENE$ are unlikely to play a major role in the susceptibility to @DISEASE$ in the Chinese population.	1
These results suggest that at least one susceptibility locus for @DISEASE$ is located within or very close to the @GENE$ region in Japanese.	1
The result of this study suggests that the @GENE$ genotype is unlikely to be associated with the risk of developing @DISEASE$.	1
The result of this study suggests that the @GENE$ genotype is unlikely to be associated with the risk of developing @DISEASE$.	1
Determination of VNTR of the @GENE$ gene may prove useful for identifying high-risk individuals for @DISEASE$.	1
The molecular abnormality demonstrated in this family provides evidence that defective synthesis of @GENE$ alters the membrane expression of the GP Ib-IX complex and may be responsible for @DISEASE$.	1
We found no evidence that mutation in GUCA1B,@GENE$,or RGS9 gene is a cause of @DISEASE$.	1
Our study indicated that a loss of @GENE$ function contributes to a major pathogenesis of X-linked @DISEASE$.	1
This study provides strong evidence linking @GENE$ polymorphisms to enhanced atrial vulnerability and increased risk of @DISEASE$.	1
The human T1663A @GENE$ gene polymorphism, which may confer lower levels of GH and IGF-I, appears to be associated with a decreased risk of @DISEASE$.	1
The human T1663A GH1 gene polymorphism, which may confer lower levels of @GENE$ and IGF-I, appears to be associated with a decreased risk of @DISEASE$.	1
The results of the current study suggest that genetic polymorphisms in the proximal promoter region and in the fourth intron of the @GENE$ gene are unrelated to @DISEASE$ risk in Chinese women.	1
Overall, we obtained no solid evidence for the involvement of the @GENE$ gene in the pathogenesis of @DISEASE$, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.	1
Overall, we obtained no solid evidence for the involvement of the @GENE$ gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of @DISEASE$.	1
Overall, we obtained no solid evidence for the involvement of the @GENE$ gene in the pathogenesis of @DISEASE$, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.	1
Overall, we obtained no solid evidence for the involvement of the @GENE$ gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of @DISEASE$.	1
These findings suggest that the -588T polymorphism of the @GENE$ gene may suppress GCLM gene induction in response to oxidants and that it is a genetic risk factor for @DISEASE$.	1
These findings suggest that the -588T polymorphism of the GCLM gene may suppress @GENE$ gene induction in response to oxidants and that it is a genetic risk factor for @DISEASE$.	1
Mutations that affect the properties of @GENE$ are found in the French population, but they do not seem to account for the linkage between the 2p23 locus and quantitative markers of @DISEASE$.	1
Our results suggest that @GENE$ gene was associated with Chinese @DISEASE$, and haplotype of GCK1/GCK2 B/2 was a protective factor for GDM.	1
Our results suggest that @GENE$ gene was associated with Chinese GDM, and haplotype of GCK1/GCK2 B/2 was a protective factor for @DISEASE$.	1
Taken together, these results demonstrate that the @GENE$*1F and GC*2 alleles are associated with sputum hypersecretion in individuals who are at increased risk of developing @DISEASE$.	1
Our results suggest that heterozygosity for a @GENE$ mutation may predispose Ashkenazi Jews to @DISEASE$.	1
The experiments reported herein provide no evidence supporting involvement of the @GENE$ locus in the development of @DISEASE$.	1
The experiments reported herein provide no evidence supporting involvement of the @GENE$ locus in the development of @DISEASE$.	1
Our results suggest that @GENE$ does not play a major role in @DISEASE$ in these two European populations.	1
Although our results are negative, this was the first study to investigate @GENE$ genes in @DISEASE$, and further studies of these genes, particularly with schizophrenia subtypes, may prove valuable.	1
Although our results are negative, this was the first study to investigate @GENE$ genes in schizophrenia, and further studies of these genes, particularly with @DISEASE$ subtypes, may prove valuable.	1
In conclusion, the present study indicates that in a population of @DISEASE$ patients, heterozygosity of the @GENE$ major (G1) allele confers higher levels of somatic symptoms, anxiety/insomnia, social dysfunction and depression than found in homozygosity.	1
The results of our study indicate that @GENE$ gene might also be involved in the genetic pathophysiology of unipolar @DISEASE$ (at least in female patients), even if the findings do not support a predominant role of GABRA 3.	1
The results of our study indicate that GABRA 3 gene might also be involved in the genetic pathophysiology of unipolar @DISEASE$ (at least in female patients), even if the findings do not support a predominant role of @GENE$.	1
These results suggest the @GENE$ gene may be a risk factor for @DISEASE$. As with the DRD2 gene, the effect may be mediated through its regulation of prolactin release.	1
These findings replicate and extend recently reported findings, which together underscore the potential contribution of polymorphic variation at the @GENE$ locus to the risk for @DISEASE$.	1
The very strong association of @GENE$ with both @DISEASE$ and the beta frequency of the electroencephalogram, combined with biological evidence for a role of this gene in both phenotypes, suggest that GABRA2 might influence susceptibility to alcohol dependence by modulating the level of neural excitation.	1
The very strong association of @GENE$ with both alcohol dependence and the beta frequency of the electroencephalogram, combined with biological evidence for a role of this gene in both phenotypes, suggest that GABRA2 might influence susceptibility to @DISEASE$ by modulating the level of neural excitation.	1
The very strong association of GABRA2 with both @DISEASE$ and the beta frequency of the electroencephalogram, combined with biological evidence for a role of this gene in both phenotypes, suggest that @GENE$ might influence susceptibility to alcohol dependence by modulating the level of neural excitation.	1
The very strong association of GABRA2 with both alcohol dependence and the beta frequency of the electroencephalogram, combined with biological evidence for a role of this gene in both phenotypes, suggest that @GENE$ might influence susceptibility to @DISEASE$ by modulating the level of neural excitation.	1
We identified no sequence variations in the @GENE$ core promoter or in the 5' UTR of these G6PD-deficient individuals, which indicates that @DISEASE$ is not associated with promoter mutations in the G6PD locus.	1
We identified no sequence variations in the G6PD core promoter or in the 5' UTR of these @GENE$-deficient individuals, which indicates that @DISEASE$ is not associated with promoter mutations in the G6PD locus.	1
We identified no sequence variations in the G6PD core promoter or in the 5' UTR of these G6PD-deficient individuals, which indicates that @DISEASE$ is not associated with promoter mutations in the @GENE$ locus.	1
We conclude that  @GENE$ A- heterozygous females are protected against all forms of P. falciparum malaria, and that the TNFalpha(-238A) allele confers protection against clinical @DISEASE$.	1
Although two prior studies have reported associations using limited numbers of SNPs on @GENE$, our intensive study failed to support any major contribution of FZD3 to @DISEASE$ susceptibility.	1
Although two prior studies have reported associations using limited numbers of SNPs on FZD3, our intensive study failed to support any major contribution of @GENE$ to @DISEASE$ susceptibility.	1
These results suggested that the @GENE$ gene might be involved in the predisposition to @DISEASE$.	1
Our data indicate that allelic variation in or near the coding regions of the @GENE$ gene does not have a major role in the inherited susceptibility to the common form of @DISEASE$.	1
In conclusion, the @GENE$/Scurfin gene appears to confer a significant susceptibility to @DISEASE$ in the Japanese population.	1
In conclusion, the FOXP3/@GENE$ gene appears to confer a significant susceptibility to @DISEASE$ in the Japanese population.	1
In conclusion, the @GENE$/Scurfin gene appears to confer a significant susceptibility to @DISEASE$ in the Japanese population.	1
In conclusion, the FOXP3/@GENE$ gene appears to confer a significant susceptibility to @DISEASE$ in the Japanese population.	1
Our results may suggest a relationship between @DISEASE$ and the @GENE$ gene or a gene located nearby.	1
The analysis did not reveal any mutation in the 240 analysed chromosomes, indicating that mutations in the @GENE$ coding region are rarely associated with non-syndromic @DISEASE$.	1
Thus, the SNPs identified in the @GENE$ gene are unlikely to have major effects on susceptibility to Japanese @DISEASE$.	1
Thus, the SNPs identified in the @GENE$ gene are unlikely to have major effects on susceptibility to Japanese @DISEASE$.	1
These data did not provide evidence for a contribution of the @GENE$ gene to susceptibility to @DISEASE$.	1
These data did not provide evidence for a contribution of the @GENE$ gene to susceptibility to @DISEASE$.	1
Although uncommon, point mutations in the @GENE$ gene may be a cause of @DISEASE$ and mental retardation in Japanese patients.	1
The @GENE$ Arg388 allele is associated with both an increased incidence and clinical aggressiveness of @DISEASE$ and results in changes in cellular motility and invasiveness in immortalized prostate epithelial cells consistent with the promotion of metastasis.	1
We conclude that  the spectrum of @GENE$ mutations causing @DISEASE$ is wider than previously recognized but that, nevertheless, the IgIIIa/IIIc region represents a genuine mutation hotspot.	1
The results showed that the @GENE$ gene is associated with autopsy-confirmed @DISEASE$.	1
Our data suggest that the fibrinogen-elevating @GENE$ G-455A gene polymorphism is not linked to an increased risk for @DISEASE$.	1
A modest association between @GENE$ and @DISEASE$ suggests that this gene and the DISC1-mediated molecular pathway might play roles in the development of schizophrenia, with FEZ1 affecting only a small subset of Japanese schizophrenia patients.	1
A modest association between @GENE$ and schizophrenia suggests that this gene and the DISC1-mediated molecular pathway might play roles in the development of @DISEASE$, with FEZ1 affecting only a small subset of Japanese schizophrenia patients.	1
A modest association between @GENE$ and schizophrenia suggests that this gene and the DISC1-mediated molecular pathway might play roles in the development of schizophrenia, with FEZ1 affecting only a small subset of Japanese @DISEASE$ patients.	1
A modest association between FEZ1 and @DISEASE$ suggests that this gene and the DISC1-mediated molecular pathway might play roles in the development of schizophrenia, with @GENE$ affecting only a small subset of Japanese schizophrenia patients.	1
A modest association between FEZ1 and schizophrenia suggests that this gene and the DISC1-mediated molecular pathway might play roles in the development of @DISEASE$, with @GENE$ affecting only a small subset of Japanese schizophrenia patients.	1
A modest association between FEZ1 and schizophrenia suggests that this gene and the DISC1-mediated molecular pathway might play roles in the development of schizophrenia, with @GENE$ affecting only a small subset of Japanese @DISEASE$ patients.	1
This study provides the first evidence that the infant @GENE$ His/His131 genotype is associated with susceptibility to perinatal @DISEASE$-1 transmission and further suggests that there is a dose-response relationship for the effect of the Fc gamma RIIa His131 gene on transmission.	1
This study provides the first evidence that the infant Fc gamma RIIa His/His131 genotype is associated with susceptibility to perinatal @DISEASE$-1 transmission and further suggests that there is a dose-response relationship for the effect of the @GENE$ His131 gene on transmission.	1
Patients with @DISEASE$ have higher frequencies of @GENE$ exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.	1
Patients with MVP have higher frequencies of @GENE$ exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of @DISEASE$ among the Chinese population in Taiwan.	1
Patients with @DISEASE$ have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the @GENE$ exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.	1
Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the @GENE$ exon 15 and 27 polymorphisms in determining the risk of @DISEASE$ among the Chinese population in Taiwan.	1
Patients with @DISEASE$ have higher frequencies of @GENE$ exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.	1
Patients with MVP have higher frequencies of @GENE$ exon 15 TT and exon 27 GG genotypes, which supports a role of the FBN1 exon 15 and 27 polymorphisms in determining the risk of @DISEASE$ among the Chinese population in Taiwan.	1
Patients with @DISEASE$ have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the @GENE$ exon 15 and 27 polymorphisms in determining the risk of MVP among the Chinese population in Taiwan.	1
Patients with MVP have higher frequencies of FBN1 exon 15 TT and exon 27 GG genotypes, which supports a role of the @GENE$ exon 15 and 27 polymorphisms in determining the risk of @DISEASE$ among the Chinese population in Taiwan.	1
In conclusion, our data do not suggest common genetic @GENE$ variants to significantly contribute to the pathogenesis of either Hashimoto's thyroiditis or @DISEASE$.	1
We conclude that  the @GENE$/FASL promoter haplotypes are functional and that polymorphisms in FAS may contribute to @DISEASE$ in SLE.	1
We conclude that  the FAS/FASL promoter haplotypes are functional and that polymorphisms in @GENE$ may contribute to @DISEASE$ in SLE.	1
Our results agree with the previously published studies and highlight that the association of the polymorphisms is restricted to women with @DISEASE$. We did not find an association between CD95L and susceptibility to MS nor @GENE$ or CD95L and age of onset, disease course and disease severity.	1
Our results agree with the previously published studies and highlight that the association of the polymorphisms is restricted to women with MS. We did not find an association between CD95L and susceptibility to @DISEASE$ nor @GENE$ or CD95L and age of onset, disease course and disease severity.	1
Taken together these data support the assertion that inherited mutations in @GENE$ can predispose to @DISEASE$.	1
It was concluded that @GENE$ genotype influences @DISEASE$ independent of body composition, habitual physical activity levels, and HRT status in postmenopausal white women	1
The Ala54Thr polymorphism of the @GENE$ gene is not associated with @DISEASE$, markers of the metabolic syndrome, or the fatty acid profile of serum lipids in Finnish CHD patients.	1
The Ala54Thr polymorphism of the @GENE$ gene is not associated with CHD, markers of the metabolic syndrome, or the fatty acid profile of serum lipids in Finnish @DISEASE$ patients.	1
In conclusion, Thr54 allele of @GENE$ has associations with lower adjusted resting metabolic rate, resistance in reducing visceral white adipose tissue (WAT) and early onset of @DISEASE$ in Japanese obese women.	1
In conclusion, Thr54 allele of @GENE$ has associations with lower adjusted resting metabolic rate, resistance in reducing visceral white adipose tissue (WAT) and early onset of obesity in Japanese @DISEASE$ women.	1
The A54T polymorphism at the @GENE$ locus is a risk factor for @DISEASE$ in a Caucasian population.	1
Our data suggested that Ala54Thr polymorphism of the @GENE$ gene is not a major contributing factor for obesity and obesity with @DISEASE$ in Japanese children.	1
These results suggest a role for the @GENE$ 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/@DISEASE$ and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.	1
In conclusion, we provide evidence for a joint effect on @DISEASE$ risk between G1691A factor V point mutation and @GENE$ Arg/Gln(353) gene polymorphism as well as between factor V point mutation and metabolic risk factors.	1
The G-455A polymorphism of the fibrinogen gene promoter and the decamer insertion or deletion polymorphism of the @GENE$ gene promoter are unlikely to be major genetic predisposing factors for @DISEASE$ in subjects from eastern Finland.	1
In conclusion, there was no association between the beta-fibrinogen -455 G/A, GP IIIa PlA1/A2, PAI-1 4G/5G, @GENE$ 1691 G/A, TNFalpha -238 G/A, TNFalpha -308 G/A, IL-1alpha -889 C/T, the IL-1beta -511 C/T, MTHFR 677 C/T and eNOS 4 b/a gene polymorphisms and the risk of @DISEASE$ after PTCA as well as recurrent restenosis after repeated PTCA.	1
In conclusion, there was no association between the beta-fibrinogen -455 G/A, GP IIIa PlA1/A2, PAI-1 4G/5G, @GENE$ 1691 G/A, TNFalpha -238 G/A, TNFalpha -308 G/A, IL-1alpha -889 C/T, the IL-1beta -511 C/T, MTHFR 677 C/T and eNOS 4 b/a gene polymorphisms and the risk of restenosis after PTCA as well as recurrent @DISEASE$ after repeated PTCA.	1
We conclude that  the 20210 G/A @GENE$ gene mutation is not a major risk factor for premature @DISEASE$ in our predominantly Caucasian Australian population.	1
We found a 6-fold higher risk of acute @DISEASE$ associated with the homozygosity of the T allele of the @GENE$, 46C-->T polymorphism in the Spanish population.	1
Our results are consistent with the hypothesis of a joint effect of @GENE$ sequence variants and endogenous estrogen exposure on @DISEASE$ risk.	1
Our results indicate that @GENE$ polymorphisms may not be associated with @DISEASE$ risk.	1
@GENE$ and VDR genes may contribute to @DISEASE$ in a distinct manner: estrogen sensitivity influences the severity in the early phase after menopause while vitamin D plays an important role at older ages when the contribution of estrogen loss is weaker.	1
@GENE$ alpha polymorphisms, but not beta3-adrenergic receptor gene, may be associated with a risk of @DISEASE$.	1
We provide evidence that variants of XRCC1, XRCC3, and @GENE$/XPF genes, particularly in combination, contribute to @DISEASE$ susceptibility.	1
We provide evidence that variants of XRCC1, XRCC3, and ERCC4/@GENE$ genes, particularly in combination, contribute to @DISEASE$ susceptibility.	1
Our findings suggest that Ki-ras and @GENE$ SNPs are possible markers for @DISEASE$ formation, whereas cyclin D1 and p16 SNPs may be markers of genes that have an inverse effect on the risk to develop meningioma in irradiated and nonirradiated populations.	1
Our findings suggest that Ki-ras and @GENE$ SNPs are possible markers for meningioma formation, whereas cyclin D1 and p16 SNPs may be markers of genes that have an inverse effect on the risk to develop @DISEASE$ in irradiated and nonirradiated populations.	1
In our population, common @GENE$ polymorphisms are not involved in predisposition to @DISEASE$.	1
In conclusion, our results support the view that both the ER codon 594 and @GENE$ codon 655 polymorphisms are not associated with increased risk of @DISEASE$.	1
Common polymorphisms within @GENE$ and EPHX2 do not appear to be important risk factors for @DISEASE$.	1
Our data show that the K1019X mutation in the @GENE$ gene differs in frequency between AA and EA, is associated with increased risk for PC in AA men with a positive family history, and may be an important genetic risk factor for @DISEASE$ in AA.	1
Although further replication studies are necessary to test the validity of the described genotype-phenotype relationship, our study supports the hypothesis that @GENE$ 121Q predicts genetic susceptibility to @DISEASE$ in both South Asians and Caucasians.	1
We conclude that  the interaction between the K121Q polymorphism of the @GENE$ gene and birth length affects insulin sensitivity and increases susceptibility to @DISEASE$ and hypertension in adulthood.	1
The authors failed to find an association between the intronic insertion polymorphism of the @GENE$ gene and aneurysmal @DISEASE$ in a Polish population.	1
In summary, the @GENE$ gene variants Leu217 and Thr541 were associated with an increased risk for @DISEASE$ and for PIN in males undergoing radical prostatectomies in the Calgary region.	1
The absence of @GENE$ mutations and lack of association between polymorphisms in ELAC2 and @DISEASE$ in cases and controls leads us to conclude that ELAC2 does not contribute significantly to the elevated prevalence of prostate cancer in Afro-Caribbean males of Tobago.	1
The absence of @GENE$ mutations and lack of association between polymorphisms in ELAC2 and prostate cancer in cases and controls leads us to conclude that ELAC2 does not contribute significantly to the elevated prevalence of @DISEASE$ in Afro-Caribbean males of Tobago.	1
The absence of ELAC2 mutations and lack of association between polymorphisms in @GENE$ and @DISEASE$ in cases and controls leads us to conclude that ELAC2 does not contribute significantly to the elevated prevalence of prostate cancer in Afro-Caribbean males of Tobago.	1
The absence of ELAC2 mutations and lack of association between polymorphisms in @GENE$ and prostate cancer in cases and controls leads us to conclude that ELAC2 does not contribute significantly to the elevated prevalence of @DISEASE$ in Afro-Caribbean males of Tobago.	1
The absence of ELAC2 mutations and lack of association between polymorphisms in ELAC2 and @DISEASE$ in cases and controls leads us to conclude that @GENE$ does not contribute significantly to the elevated prevalence of prostate cancer in Afro-Caribbean males of Tobago.	1
The absence of ELAC2 mutations and lack of association between polymorphisms in ELAC2 and prostate cancer in cases and controls leads us to conclude that @GENE$ does not contribute significantly to the elevated prevalence of @DISEASE$ in Afro-Caribbean males of Tobago.	1
There is no evidence that either @GENE$ polymorphism is associated with @DISEASE$ or PSA level.	1
The present study suggested that the common variants in the @GENE$/ELAC2 gene play a limited role in the risk of @DISEASE$ in the Japanese population.	1
The present study suggested that the common variants in the HPC2/@GENE$ gene play a limited role in the risk of @DISEASE$ in the Japanese population.	1
The present study suggested that the common variants in the @GENE$/ELAC2 gene play a limited role in the risk of @DISEASE$ in the Japanese population.	1
The present study suggested that the common variants in the HPC2/@GENE$ gene play a limited role in the risk of @DISEASE$ in the Japanese population.	1
In conclusion, our findings support an etiological role of @GENE$ in @DISEASE$ development.	1
This is the second study to find no association between @GENE$ +61 and @DISEASE$ susceptibility.	1
Our results suggest that the polymorphism in @GENE$ gene might not confer increased susceptibility for @DISEASE$ in a Japanese population.	1
Our findings suggest that the A-G polymorphism of @GENE$ is involved not only in the occurrence but also in the malignant progression of @DISEASE$.	1
This study suggests that high @GENE$ production might be important in the development of @DISEASE$.	1
This study suggests that high @GENE$ production might be important in the development of @DISEASE$.	1
All our results indicate that the presence of the @GENE$ genotype (++) in patients with structural heart disease, severe left ventricular dysfunction and malignant ventricular @DISEASE$ increases the risk for these patients of hemodynamic collapse during these arrhythmias.	1
All our results indicate that the presence of the @GENE$ genotype (++) in patients with structural heart disease, severe left ventricular dysfunction and malignant ventricular arrhythmias increases the risk for these patients of hemodynamic collapse during these @DISEASE$.	1
The @GENE$ gene polymorphism in this study did not seem to be associated with the incidence of @DISEASE$ among the Japanese workers.	1
It follows that the examined polymorphisms in the genes for ACE, angiotensinogen, and @GENE$ could participate in the etiopathogenesis of @DISEASE$ diseases.	1
Thus, in contrast to prior studies reporting positive association of the @GENE$ gene with @DISEASE$ in both Irish and German population, our data indicate that the human DTNBP1 is unlikely a major susceptible gene for schizophrenia in Chinese Han patients from Taiwan.	1
Thus, in contrast to prior studies reporting positive association of the @GENE$ gene with schizophrenia in both Irish and German population, our data indicate that the human DTNBP1 is unlikely a major susceptible gene for @DISEASE$ in Chinese Han patients from Taiwan.	1
Thus, in contrast to prior studies reporting positive association of the DTNBP1 gene with @DISEASE$ in both Irish and German population, our data indicate that the human @GENE$ is unlikely a major susceptible gene for schizophrenia in Chinese Han patients from Taiwan.	1
Thus, in contrast to prior studies reporting positive association of the DTNBP1 gene with schizophrenia in both Irish and German population, our data indicate that the human @GENE$ is unlikely a major susceptible gene for @DISEASE$ in Chinese Han patients from Taiwan.	1
Our study provides further evidence for a role of the @GENE$ gene in the genetic etiology of @DISEASE$.	1
We conclude that  the @GENE$ *2236 C allele may mark another polymorphism in DRP-2, or in a nearby gene, that may influence susceptibility to @DISEASE$.	1
We conclude that  the DRP-2 *2236 C allele may mark another polymorphism in @GENE$, or in a nearby gene, that may influence susceptibility to @DISEASE$.	1
Our results suggest that the *2236C allele in the 3'UTR of the @GENE$ gene, or an unknown mutation in linkage disequilibrium with this allele, may reduce the susceptibility to @DISEASE$, especially the paranoid subtype.	1
These results suggest that the *2236C allele in the 3'UTR of the @GENE$ gene, or an unknown mutation in linkage disequilibrium with this allele, may reduce the susceptibility to @DISEASE$, especially the paranoid subtype.	1
These results provide further evidence of an association between @GENE$ and @DISEASE$, supporting the involvement of the dopamine pathway in the pathogenesis of CD.	1
The present results do not support a major role for @GENE$ in the etiology of @DISEASE$ among Caucasians from Sweden.	1
In children with @DISEASE$, possession of the @GENE$ 7-repeat allele appears to be associated with an inaccurate, impulsive response style on neuropsychological tasks that is not explained by ADHD symptom severity.	1
In children with ADHD, possession of the @GENE$ 7-repeat allele appears to be associated with an inaccurate, impulsive response style on neuropsychological tasks that is not explained by @DISEASE$ symptom severity.	1
In children with @DISEASE$, possession of the @GENE$ 7-repeat allele appears to be associated with an inaccurate, impulsive response style on neuropsychological tasks that is not explained by ADHD symptom severity.	1
In children with ADHD, possession of the @GENE$ 7-repeat allele appears to be associated with an inaccurate, impulsive response style on neuropsychological tasks that is not explained by @DISEASE$ symptom severity.	1
Our results suggest that MAO-A, COMT, 5-HT2A, DRD2, and @GENE$ gene variants are not involved in susceptibility toward different time courses in @DISEASE$.	1
The present results do not support a major role for @GENE$ in the etiology of @DISEASE$ among Caucasians from Sweden.	1
Overall our results indicates that the HTR2A, 5-HTT, @GENE$ and GABA(A)gamma2 genes are not likely to be a major genetic risk factor for @DISEASE$ in this population, with the exception of possible association between nasal inhalation and DRD2 promoter - 141DeltaC polymorphism.	1
There is good evidence that gene coding for the @GENE$ does not play a major role in the genetic vulnerability to @DISEASE$.	1
These results suggest that the S/S genotype of the @GENE$ is associated with worse therapeutic response and more severe executive dysfunctions in patients with @DISEASE$.	1
We suggest that the @GENE$ Ser9Gly polymorphism may be a contributing factor to the performance of eye movements used as a phenotypic marker of @DISEASE$.	1
Although there remains a possibility that the @GENE$ TaqI A polymorphism plays some role in modifying the phenotype of the disease, these results suggest that neither the A1 allele nor the homozygous A1 genotype is associated with @DISEASE$.	1
The results suggest that both the @GENE$ promoter region and the DAT gene do not play a significant role in conferring vulnerability to @DISEASE$.	1
Our findings indicate that the @GENE$ -141C Ins allele and the 5-HTTLPR S allele are genetic risk factors for @DISEASE$ in Mexican-Americans, and that smoking modulates the association between genetic risk factors and alcoholism.	1
Our findings indicate that the @GENE$ -141C Ins allele and the 5-HTTLPR S allele are genetic risk factors for alcoholism in Mexican-Americans, and that smoking modulates the association between genetic risk factors and @DISEASE$.	1
These findings suggest that the TaqI A @GENE$) polymorphism is associated with the predisposition to @DISEASE$.	1
We conclude that  our data do not support an allelic association between the A1 allele at @GENE$ and @DISEASE$.	1
Our results suggest that MAO-A, COMT, 5-HT2A, @GENE$, and DRD4 gene variants are not involved in susceptibility toward different time courses in @DISEASE$.	1
Examination of specific @GENE$ gene polymorphism in 247 Japanese @DISEASE$ patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in DLST genotypes and failed to replicate the findings of earlier studies indicating an association between DLST gene polymorphism and AD.	1
Examination of specific @GENE$ gene polymorphism in 247 Japanese AD patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in DLST genotypes and failed to replicate the findings of earlier studies indicating an association between DLST gene polymorphism and @DISEASE$.	1
Examination of specific DLST gene polymorphism in 247 Japanese @DISEASE$ patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in @GENE$ genotypes and failed to replicate the findings of earlier studies indicating an association between DLST gene polymorphism and AD.	1
Examination of specific DLST gene polymorphism in 247 Japanese AD patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in @GENE$ genotypes and failed to replicate the findings of earlier studies indicating an association between DLST gene polymorphism and @DISEASE$.	1
Examination of specific DLST gene polymorphism in 247 Japanese @DISEASE$ patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in DLST genotypes and failed to replicate the findings of earlier studies indicating an association between @GENE$ gene polymorphism and AD.	1
Examination of specific DLST gene polymorphism in 247 Japanese AD patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in DLST genotypes and failed to replicate the findings of earlier studies indicating an association between @GENE$ gene polymorphism and @DISEASE$.	1
This study provides support for the hypothesis that @GENE$ constitutes a true @DISEASE$ risk factor of modest effect.	1
The @GENE$ genotype appears to operate independently of APOE in conferring @DISEASE$ risk.	1
These results suggest that @GENE$ is unlikely to play an important role in @DISEASE$ susceptibility.	1
These results suggest that @GENE$ is unlikely to play an important role in @DISEASE$ susceptibility.	1
These results suggest that the genomic interval of @GENE$ probably involved in transcriptional regulation does not display major genetic relevance in Japanese @DISEASE$ patients.	1
Although the T79C SNP of the @GENE$ gene was studied in several groups of white subjects, the association between this SNP and @DISEASE$-related phenotypes, previously described, was not confirmed in our population.	1
Variation in @GENE$ contributes to @DISEASE$ diagnosis, with apparent gender-specific effects.	1
Genetic variations in @GENE$ may define a high-risk subgroup of @DISEASE$ where the component of chronic bronchitis is predominant.	1
Genetic variations in @GENE$ may define a high-risk subgroup of @DISEASE$ where the component of chronic bronchitis is predominant.	1
Genetic variations in @GENE$ may define a high-risk subgroup of @DISEASE$ where the component of chronic bronchitis is predominant.	1
Genetic variations in @GENE$ may define a high-risk subgroup of @DISEASE$ where the component of chronic bronchitis is predominant.	1
The observed haplotypic association provides the first evidence of the importance of @GENE$ polymorphisms in @DISEASE$ susceptibility.	1
No association was observed between the Arg201Gly polymorphism of @GENE$ and @DISEASE$ risk.	1
These results suggest that @GENE$ does not contribute to the development of @DISEASE$ in Japanese.	1
In a selected Caucasian population, the @GENE$ SNP 386 is completely absent and SNP 260 is not associated with spermatogenic failure and therefore does not represent a molecular marker for genetic diagnosis of @DISEASE$.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between @DISEASE$ and a @GENE$ haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with schizophrenia and indicates that the DAAO gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between schizophrenia and a @GENE$ haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with @DISEASE$ and indicates that the DAAO gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between schizophrenia and a @GENE$ haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with schizophrenia and indicates that the DAAO gene may play a significant role in the etiology of @DISEASE$ in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between @DISEASE$ and a DAAO haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the @GENE$ gene with schizophrenia and indicates that the DAAO gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between schizophrenia and a DAAO haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the @GENE$ gene with @DISEASE$ and indicates that the DAAO gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between schizophrenia and a DAAO haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the @GENE$ gene with schizophrenia and indicates that the DAAO gene may play a significant role in the etiology of @DISEASE$ in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between @DISEASE$ and a DAAO haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with schizophrenia and indicates that the @GENE$ gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between schizophrenia and a DAAO haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with @DISEASE$ and indicates that the @GENE$ gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	1
In the haplotype analysis based on the information of linkage-disequilibrium block across this gene locus, we demonstrated a highly significant association between schizophrenia and a DAAO haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with schizophrenia and indicates that the @GENE$ gene may play a significant role in the etiology of @DISEASE$ in the Han Chinese.	1
Our findings could not demonstrate any involvement of POF1B, but suggest that rare mutations in the @GENE$ gene may have a role in the @DISEASE$ phenotype.	1
Here we report that polymorphisms within the APOE promoter, ACE1 and @GENE$ gene are not risk factors for @DISEASE$ and are not associated with parenchymal or vascular accumulation of Abeta.	1
Our results indicate that the intron 2 @GENE$ C/C genotype may predispose to @DISEASE$, and this association is independent of the apolipoprotein E genotype.	1
These findings provide direct evidence that @GENE$ and ApoE polymorphisms synergically increase the risk for @DISEASE$ development, and influence on the rate of cognitive decline.	1
Our data indicate that the Intron 2 polymorphism of @GENE$ does not affect the risk of @DISEASE$ in our sample.	1
Our results indicate that the @GENE$ gene locus may predispose to @DISEASE$ by increasing the 24S-hydroxycholesterol/cholesterol ratio in the brain.	1
@GENE$ influences brain beta-amyloid load, cerebrospinal fluid levels of beta-amyloid peptides and phosphorylated tau, and the genetic risk of late-onset sporadic @DISEASE$.	1
The observation that CYP3A4 and @GENE$ were associated with @DISEASE$, are not in linkage equilibrium, and are both involved in testosterone metabolism, suggest that both CYP3A4*1B and CYP3A43*3 may influence the probability of having prostate cancer and disease severity.	1
The observation that CYP3A4 and @GENE$ were associated with prostate cancer, are not in linkage equilibrium, and are both involved in testosterone metabolism, suggest that both CYP3A4*1B and CYP3A43*3 may influence the probability of having @DISEASE$ and disease severity.	1
The observation that CYP3A4 and CYP3A43 were associated with @DISEASE$, are not in linkage equilibrium, and are both involved in testosterone metabolism, suggest that both CYP3A4*1B and @GENE$*3 may influence the probability of having prostate cancer and disease severity.	1
The observation that CYP3A4 and CYP3A43 were associated with prostate cancer, are not in linkage equilibrium, and are both involved in testosterone metabolism, suggest that both CYP3A4*1B and @GENE$*3 may influence the probability of having @DISEASE$ and disease severity.	1
@GENE$ influences brain beta-amyloid load, cerebrospinal fluid levels of beta-amyloid peptides and phosphorylated tau, and the genetic risk of late-onset sporadic @DISEASE$.	1
Our results suggest that the @GENE$-Pro(340)Ala polymorphism contributes to @DISEASE$ risk.	1
A functionally relevant polymorphism of the @GENE$ gene is independently associated with an increased risk of @DISEASE$.	1
The @GENE$ C2 allele is a susceptibility factor for @DISEASE$, especially for colon cancer, and there is an apparent gene-environment interaction between the susceptible genotype and salted food.	1
The @GENE$ c1/c1 genotype is a susceptibility factor for development of @DISEASE$ in Chinese and there is an apparent gene-environment interaction between the susceptible genotype and cigarette smoking.	1
These data establish a whole-gene, high-resolution haplotype structure for @GENE$ in a European American patient population and suggest that genetic variation in exons, rather than the promoter or other regulatory regions, is largely responsible for @DISEASE$ associated with CYP2C9 variants in this population.	1
These data establish a whole-gene, high-resolution haplotype structure for CYP2C9 in a European American patient population and suggest that genetic variation in exons, rather than the promoter or other regulatory regions, is largely responsible for @DISEASE$ associated with @GENE$ variants in this population.	1
The results suggest that @GENE$ genetic polymorphism may be related to a @DISEASE$ due to an alteration in endogenous metabolism, although a linkage between CYP2C9 and some other gene related to depression cannot be ruled out.	1
The results suggest that CYP2C9 genetic polymorphism may be related to a @DISEASE$ due to an alteration in endogenous metabolism, although a linkage between @GENE$ and some other gene related to depression cannot be ruled out.	1
Association between @GENE$ polymorphism and @DISEASE$ risk was not identified in this study.	1
These results do not support the hypothesis that @DISEASE$ resulting from NSAID usage is linked to the poor metabolizing genotypes of @GENE$.	1
The effect of @GENE$ polymorphisms on nateglinide kinetics may cause a slightly increased risk for @DISEASE$, which may become relevant in diabetic patients.	1
Our results suggest that rate of gastric emptying, but not @GENE$ polymorphism, is likely to be an important factor in the delayed healing of patients with PPI-resistant @DISEASE$.	1
Our data suggest that deficient @GENE$ activity due to genetic polymorphism reduces @DISEASE$ risk in betel quid chewers.	1
In this Caucasian population, we found neither a relation between genetically impaired nicotine metabolism and cigarette consumption, nor any modification of @DISEASE$ risk related to the presence of defective @GENE$ alleles (odds ratio = 1.1, 95% confidence interval = 0.7-1.9).	1
This study suggests that the @GENE$ gene does not play a major role as a @DISEASE$ susceptibility gene.	1
The results suggest that the CYP19 Arg(264)Cys polymorphism modifies @DISEASE$ risk (OR=1.5, 95% CI=1.1-2.2), especially in association with alcohol consumption (P for interaction=0.04), whereas the @GENE$ Leu(432)Val polymorphism appears to play no role here.	1
Our data shows no association between @DISEASE$ and the Leu432Val polymorphism of the @GENE$ gene or the tetranucleotide repeats of the CYP19 gene.	1
Our study showed that gene polymorphisms of @GENE$ and SULT1A1 induce an individual susceptibility to @DISEASE$ among current smokers.	1
We conclude that  the @GENE$* 3 allele appears to be a factor for susceptibility to @DISEASE$ in Turkish women especially those with a BMI greater than 24 kg/m(2).	1
Our results suggested that the Val @GENE$ allele increases the susceptibility to @DISEASE$ in women exposed to waste incinerator or agricultural pollutants.	1
These results do not support a favoring role of @GENE$*3 in @DISEASE$ development in our population.	1
We found no evidence for an overall association between @GENE$ genotype and @DISEASE$ risk, nor was there any clear indication of gene-environment interaction.	1
These results suggest that HLA class I antigens and @GENE$ A-308G are not associated with susceptibility or resistance to the development of TDI-induced @DISEASE$.	0
These results suggest that the C1772T polymorphism in @GENE$ is not involved in @DISEASE$ or metastasis of colorectal carcinoma.	0
These results provide substantial evidence that genetic variation within or extremely close to @GENE$ impacts both @DISEASE$ risk and traits related to the severity of AD.	0
This study provides the first evidence that @GENE$ may be a candidate susceptibility loci that affects the @DISEASE$ of atherosclerosis in Japanese subjects.	0
Since only eight out @GENE$ iron-overloaded HbH patients carry a @DISEASE$ in the TFR2 or HFE gene in the heterozygote state and their iron loading status was comparable to the matched controls without such defects, it would appear that the accumulation of excess iron in HbH disease is more likely a result of increase dietary absorption secondary to ineffective erythropoiesis.	0
The H63D @DISEASE$ of the @GENE$ gene has a moderate but significant influence on sTfR concentration in the general population, the presence of one or two mutated alleles being associated with an average of 0.27 mg/L less sTfR than nonmutated homozygotes.	0
In Mediterranean populations from Southern Italy the C282Y @DISEASE$ occurs sporadically and @GENE$ polymorphisms seem to have little diagnostic relevance.	0
@GENE$ genotype GG is associated with cirrhosis in patients with @DISEASE$.	0
C282Y and H63D mutations do not appear to be associated with an increased risk of @GENE$ in patients with @DISEASE$.	0
The clinical @DISEASE$ and laboratory findings of the patient and his relatives are consistent with the conclusion that the E168Q mutation by itself is unlikely to result in @GENE$.	0
Our prospective findings suggest that individuals carrying the @GENE$ C282Y @DISEASE$ may be at increased risk of CHD.	0
We conclude that  homozygosity for the G1514-->A @DISEASE$ is exclusively responsible for the adult form of Sandhoff disease in this family, and that the A619-->G substitution is not a deleterious mutation but rather a common @GENE$ polymorphism.	0
The results further support the evidence that the repeat expansion at the chromosome 16q24.3 locus is the direct cause of @GENE$ and provide preliminary guidelines for the genetic testing of patients with an @DISEASE$-like phenotype.	0
These findings suggest that an increase in the size of the normal repeat may mitigate the expression of the @DISEASE$ among @GENE$ affected persons with large expanded CAG repeats.	0
The novel gene @GENE$ may be related with the @DISEASE$ and proliferation of liver cancer.	0
@DISEASE$ mutations of @GENE$/42, CD17, CD71/72, IVS-II-654 had no influence on Hb F levels, but (G)Gamma-158(C-->T) had a strong association with moderately increased Hb F levels in beta-thalassemia heterozygotes in the Guangxi area of China.	0
Our findings suggest that the genetic variants of the TIM-1 but not the @GENE$ gene contribute to @DISEASE$ susceptibility in this African-American population.	0
Our results suggest that the @GENE$ 168His variant is associated with reduced susceptibility to @DISEASE$.	0
We found no evidence that @DISEASE$ in @GENE$,GNGT1,or RGS9 gene is a cause of retinitis pigmentosa.	0
Statistical analysis indicates that there is no association of the @GENE$ variant and hence the gene does not appear to play a significant role in the development of @DISEASE$.	0
Our findings indicate that the polymorphisms of the @GENE$, CYP2E1, and GSTT1 genes probably play a substantial part in susceptibility to severe airway and lung injury in cases of children with @DISEASE$ and relapsing pneumonia.	0
Our findings support the view that @GENE$ genotypes contribute to the individual @DISEASE$ risk, especially in certain combinations.	0
We conclude that genetic alterations in the @GENE$, GSTM3, GSTT1, and GSTM1 genes do not play a dominant role in @DISEASE$.	0
These results support previous reports that the GSTM1 null genotype is associated with a modest increase in risk for @DISEASE$, particularly among heavy smokers, suggest no role for GSTT1 and the need for further study of @GENE$.	0
We conclude that  the two polymorphisms, GSTT1 null and PON1 BB, are common genetic @GENE$ that pose low individual risk but may be important determinants of overall population @DISEASE$ risk, particularly among groups exposed to NHL-related carcinogens.	0
Polymorphisms in the @DISEASE$-related genes (@GENE$, GSTM1, GSTT1, MPO, MnSOD) do not seem to be risk factors for preeclampsia.	0
The @GENE$-null genotype may increase the risk for HL and is associated with favorable prognostic factors, and the presence of at least one GST @DISEASE$ indicates an improved disease-free survival.	0
Genetic @DISEASE$ of the @GENE$ enzyme is an independent and powerful predictor of premature vascular morbidity and death in individuals with type 2 diabetes.	0
In conclusion, @GENE$, GSTM1, and GSTP1 genotyping seems to be a risk predictor of BPDE-@DISEASE$ in leukocytes.	0
The results suggest for the first time that in addition to @GENE$, the NATs play an important role in inception of @DISEASE$ reactions related to occupational exposure to diisocyanates.	0
Our findings suggest that the polymorphism (Ile105Val) on exon 5 of the @GENE$ gene may contribute to a vulnerability to @DISEASE$ associated with MAP abuse in Japanese population.	0
Our findings suggest that genetic variability in members of the @GENE$ gene family may be associated with an increased susceptibility to @DISEASE$.	0
The @GENE$ Ile(105)Val polymorphism is associated in a dose-dependent fashion with increased survival of patients with advanced @DISEASE$ receiving 5-FU/oxaliplatin chemotherapy.	0
Our findings suggest that interactions of polymorphic genotypes within the @GENE$ gene cluster affect individual susceptibility to colorectal @DISEASE$, the GSTM3*B variant presence being a risk factor especially in combination with the GSTM1-null genotype.	0
Significant associations between genetic polymorphisms in @GENE$, NQO1 and mEH gene and risk for chromosomal damage were found among occupational PAH-exposed workers, which related to the mechanism of PAH @DISEASE$.	0
This study suggests that the @GENE$ polymorphism and its combination with GSTM1 may be associated with @DISEASE$ susceptibility in the Japanese population.	0
These data suggest that polymorphisms in @GENE$ and GSTM1 contribute to the increased risk of females for @DISEASE$.	0
These findings suggest that the cause of @GENE$ gene @DISEASE$ in smokers with lung adenocarcinoma may be in part an accumulation of BP diol epoxide which is not well detoxified in individuals with the GSTM1 null genotype.	0
The combination of @GENE$ genotype 0/0 and matrix metalloproteinase 9 @DISEASE$ allele (-15621) is a risk factor for chronic obstructive pulmonary disease (OR-7.7).	0
Our data suggested that the @DISEASE$ of 29-bp nucleotides in the promoter region of the @GENE$ gene associates with the development of PD	0
These results suggest that the association between urinary 1-OHPG and @GENE$ @DISEASE$ might be modulated by the GSTM1 genotype.	0
The @GENE$-null genotype may be associated with an increased risk of HCC, but not of @DISEASE$ and LC.	0
Individuals with homozygous @DISEASE$ of the @GENE$ gene and a NAT2 slow-acetylator genotype who are exposed to high levels of asbestos appear to have enhanced susceptibility to asbestos-related pulmonary disorders.	0
No associations between the @GENE$ alleles, including the @DISEASE$, and cataracts were detected in this study.	0
Results warrant interest for the variants of genes pertaining to the molecular @GENE$ as possible endophenotypes of @DISEASE$, but caution ought to be taken in interpreting these preliminary results and future replication studies must be awaited.	0
These data suggest that polymorphisms in the @GENE$ gene may be useful as predictors of negative @DISEASE$ improvement in persons with schizophrenia treated with olanzapine.	0
These results suggest that variants in NMDAR genes are associated with @DISEASE$ and related @GENE$.	0
revealed no significant association between schizophrenia and the SNPs in the upstream region of @GENE$, these SNPs apparently do not play a critical role in the @DISEASE$ of schizophrenia in the Japanese population.	0
We conclude that  @GENE$ does not play a major role in the @DISEASE$ of schizophrenia in the Japanese population.	0
We conclude that  @GENE$ does not play a major role in schizophrenia @DISEASE$ in the Japanese population.	0
These results suggest that functional variants in the @GENE$ gene are associated with increased IMT of carotid arteries and risk of cardiovascular and @DISEASE$ in type 2 diabetic patients.	0
the @DISEASE$ is responsible for a @GENE$ phenotype observed in the patient.	0
Our results suggest that the @GENE$ Met/VNTR B haplotype of the platelet @DISEASE$ factor and thrombin receptor protein GP Ib-V-IX may be considered to be a major risk factor of coronary thrombosis, fatal MI, and SCD in early middle age.	0
In conclusion, platelet @GENE$ Ia C807T and GP Ib C3550T polymorphisms in our population are less common compared with Caucasians, and GP IIIa Pl(A1/A2) genetic @DISEASE$ is not found, and all of them are not associated with ischemic stroke in young Taiwanese.	0
It was concluded that the Kozak T/C polymorphism, which is associated with an increase in platelet @GENE$ Ibalpha surface expression, is an independent risk factor for first-ever @DISEASE$.	0
In an unstable coronary @DISEASE$ population the T-5C polymorphism in GPIb(alpha) influences risk of subsequent @GENE$.	0
The @DISEASE$ identified in the family studied, responsible for the deficiency of the @GENE$ Ib/IX/V complex, suggests that the cysteine at amino acid position 209 may be involved in disulphide bonding.	0
The @DISEASE$ demonstrated in this family provides evidence that defective synthesis of @GENE$ alters the membrane expression of the GP Ib-IX complex and may be responsible for Bernard-Soulier syndrome.	0
Polymorphic markers of @GENE$ and GNB3 candidate genes influence clinical diversity of pathological signs in DM2 patients through modification of AH and @DISEASE$ severity and the level of proinflammatory cytokines.	0
Although the effect of the gene on each phenotype appears to be @DISEASE$, considering the combined @GENE$ of the effects of the C825T polymorphism on risk factors, the GNB3 gene may be an important gene for human health.	0
In conclusion, our results suggest an association between @DISEASE$ and the C825T allele of the G-protein @GENE$ subunit gene.	0
The current findings of the study suggest that increased body fatness along with low cardiorespiratory fitness may magnify the genetic susceptibility of the @GENE$ 825T allele to elevated @DISEASE$ pressure in this study population.	0
These results indicate that the @GENE$ C825T polymorphism has no major influence on the pressor response to salt in @DISEASE$ and therefore do not support its usefulness as an early genetic marker of salt sensitivity in this disease.	0
The T825 allele of @GENE$ is associated with increased serum potassium and total cholesterol levels but not with @DISEASE$ pressure in a Japanese population.	0
We conclude that the C825T polymorphism of the G-protein @GENE$ subunit gene does not notably contribute to the development of @DISEASE$ or obesity, and is not a significant determinant for blood pressure and body mass index in white men.	0
In summary, our results demonstrate that the @GENE$ 825T allele is associated with reduced @DISEASE$ in men with abdominal fat distribution and with more advanced carotid atherosclerosis in middle-aged white men and women.	0
These results suggested that alterations in @GENE$ (or a closely linked gene) were associated with the development and @DISEASE$ of oligodendroglioma.	0
Our data suggest that @GENE$ alterations are common but have no or a low genetic relevance in the Austrian hearing @DISEASE$ population with or without Cx26 alterations.	0
None of these patients was carrying the @DISEASE$ in @GENE$ indicating that the occurrence of this deletion is restricted to certain populations.	0
Screening for @GENE$ mutations in DNA recovered from buccal smears of individuals with inherited hearing @DISEASE$ offers an easy, non-invasive method for early diagnosis and a basis of genetic counselling.	0
The identification of @GENE$ as the DFNB1 gene should provide a better understanding of the biology of normal and abnormal hearing, help form the basis for diagnosis and may facilitate development of strategies for treatment of this common @DISEASE$.	0
Our study indicated that a loss of @GENE$ function contributes to a major @DISEASE$ of X-linked Charcot-Marie-Tooth disease.	0
In conclusion, we did not obtain conclusive evidence for an involvement of the @GENE$ gene in @DISEASE$ regulation or SNS in our study groups.	0
The human T1663A GH1 gene polymorphism, which may confer lower levels of GH and @GENE$, appears to be associated with a decreased risk of @DISEASE$.	0
Overall, we obtained no solid evidence for the involvement of the @GENE$ gene in the @DISEASE$ of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.	0
Genetic variation in @GENE$ is thus unlikely to have a major impact on susceptibility to @DISEASE$.	0
Our results suggest that GCK gene was associated with Chinese @DISEASE$, and haplotype of GCK1/GCK2 @GENE$ was a protective factor for GDM.	0
These findings support a role for genetic variants within the GABA receptor gene complex in 15q11-@GENE$ in @DISEASE$.	0
We conclude that  the -30 beta-@GENE$ GCK gene promoter variant is associated with reduced beta-cell function in middle-aged Japanese-American men and may contribute to the high risk of abnormal glucose @DISEASE$ in this population.	0
These results indicate that the variant (-30) of the islet promoter region of the @GENE$ gene does not have a significant effect on insulin secretion in Finnish subjects with NGT, IGT, or @DISEASE$.	0
The Gly40Ser polymorphism of the @GENE$-R gene is associated with central @DISEASE$ independently from total body mass in men.	0
Taken together, these results demonstrate that the GC*1F and @GENE$ alleles are associated with sputum hypersecretion in individuals who are at increased risk of developing @DISEASE$.	0
Our results suggest that heterozygosity for a @GENE$ @DISEASE$ may predispose Ashkenazi Jews to Parkinson's disease.	0
We conclude that  the nature of the amino acid substitution at position 218 of the Nf of @GENE$ is of crucial importance in determining the severity of the phenotype in @DISEASE$ patients and possibly also in inducing skewed X inactivation.	0
It is unlikely that either maternal or fetal @GENE$ enzyme activity could affect paramesonephric duct development, because neither galactosaemic subjects nor their children have an increased incidence of @DISEASE$.	0
We conclude that  the @GENE$ N314D allele does not predispose to @DISEASE$.	0
We conclude that  the N314D @DISEASE$ is a common allele that probably causes the Duarte @GENE$ biochemical phenotype and occurs in a predominantly Caucasian, nongalactosemic population, with a prevalence of 5.9%.	0
Our data suggest that @GENE$ is involved in the @DISEASE$ of NSCLP in the Japanese population.	0
In conclusion, the present study indicates that in a population of PTSD patients, heterozygosity of the @GENE$ major (G1) allele confers higher levels of somatic @DISEASE$, anxiety/insomnia, social dysfunction and depression than found in homozygosity.	0
Results with @GENE$ and DRD4 genes indicate that these two genes may not play major roles in the development of @DISEASE$.	0
These findings support a role for the serotonin transporter and GABA(A) alpha6 subunit in @DISEASE$-related @GENE$.	0
These results suggest that the T1521C polymorphism in the @GENE$ gene is associated with specific @DISEASE$ characteristics as well as a marked attenuation in hormonal and blood pressure responses to psychological stress.	0
These results suggest that the @GENE$ gene may confer susceptibility to @DISEASE$.	0
The presence or @DISEASE$ of the 282-bp allele in the genotype of @GENE$ patients was not shown to influence the age of onset and the overall clinical severity, but was found to be associated with a preponderance of manic over depressive episodes in the course of the illness.	0
This study can rule out even small size effects in the total sample and suggests a lack of association between @GENE$ polymorphism and @DISEASE$, in the Spanish population.	0
The results of our study indicate that @GENE$ gene might also be involved in the genetic @DISEASE$ of unipolar major depressive disorder (at least in female patients), even if the findings do not support a predominant role of GABRA 3.	0
These findings suggest that genetic variants of @GENE$ increase risk for @DISEASE$ in the Russian population and provide additional support to the hypothesis that polymorphic variation at the GABRA2 locus plays an important role in predisposing to AD at least in European-ancestry populations.	0
These data did not support our hypothesis that polymorphisms of the @GENE$ gene may confer vulnerability for @DISEASE$.	0
We postulate that the @GENE$ gene might not be a susceptibility gene for @DISEASE$ at least in the Chinese population.	0
We identified no sequence variations in the G6PD core promoter or in the 5' @GENE$ of these G6PD-deficient individuals, which indicates that @DISEASE$ is not associated with promoter mutations in the G6PD locus.	0
We conclude that  @GENE$ A- heterozygous females are protected against all forms of @DISEASE$ malaria, and that the TNFalpha(-238A) allele confers protection against clinical malaria.	0
Our results indicate a possible association of @DISEASE$ with a genotype of the SNP T137346C of the @GENE$ fyn, with C being the risk allele.	0
The results showed that none of them had the @DISEASE$, indicating that genetic defects in the @GENE$ gene are unlikely to be a common cause of typical PD, at least in a North America population.	0
The @GENE$ Ser680/Ser680 genotype is associated with higher ovarian threshold to FSH, decreased negative feedback of luteal secretion to the pituitary during the intercycle @DISEASE$, and longer menstrual cycles.	0
The analysis did not reveal any @DISEASE$ in the 240 analysed chromosomes, indicating that mutations in the @GENE$ coding region are rarely associated with non-syndromic POF.	0
Our data indicate that variation in @GENE$ may have a @DISEASE$ role in body weight control and seems to be involved in the regulation of basal glucose turnover and plasma triglyceride levels in women, but this gene does not significantly contribute to the etiology of type 2 diabetes in Pima Indians.	0
We conclude that @GENE$ is associated with @DISEASE$ and metabolic deterioration but does not contribute to an increased risk for type 2 diabetes.	0
Our data suggest that @GENE$ is a @DISEASE$ but consistent candidate gene for obesity and dyslipidemia.	0
These data suggest that the presence of the H475Y @GENE$ allele impairs the intestinal absorption of dietary folates, resulting in relatively low @DISEASE$ folate levels and consequent hyperhomocysteinemia.	0
We conclude that  genotypes of the @GENE$ gene are useful prognostic factors in SSc, helping to predict individuals likely to develop @DISEASE$.	0
These findings support a central role of genes regulating the @GENE$ axis in the causality of @DISEASE$ and the mechanism of action of antidepressant drugs.	0
Our results support the conclusion that the @GENE$ Arg(388) allele represents a determinant that is innocuous in healthy individuals but predisposes @DISEASE$ patients for significantly accelerated disease progression.	0
The @GENE$ Arg388 allele is associated with both an increased incidence and clinical @DISEASE$ of prostate cancer and results in changes in cellular motility and invasiveness in immortalized prostate epithelial cells consistent with the promotion of metastasis.	0
We conclude that  the spectrum of @GENE$ mutations causing craniosynostosis is wider than previously recognized but that, nevertheless, the IgIIIa/IIIc region represents a genuine @DISEASE$ hotspot.	0
The G-455A polymorphism of the fibrinogen gene promoter and the decamer insertion or @DISEASE$ polymorphism of the @GENE$ gene promoter are unlikely to be major genetic predisposing factors for preeclampsia in subjects from eastern Finland.	0
In conclusion, there was no association between the beta-fibrinogen -455 G/A, @GENE$ IIIa PlA1/A2, PAI-1 4G/5G, factor V Leiden 1691 G/A, TNFalpha -238 G/A, TNFalpha -308 G/A, IL-1alpha -889 C/T, the IL-1beta -511 C/T, MTHFR 677 C/T and eNOS 4 b/a gene polymorphisms and the risk of @DISEASE$ after PTCA as well as recurrent restenosis after repeated PTCA.	0
While the results should be interpreted with caution as the frequency of the -455A allele is rare, the -455A allele of the beta-fibrinogen gene does not appear to be associated with an increased risk of @GENE$ or @DISEASE$.	0
beta fibrinogen gene -455G/A polymorphism is associated with increased plasma fibrinogen levels and may be an important risk factor in the @DISEASE$ of @GENE$.	0
The present study demonstrates that neither the Bgl @GENE$ gene polymorphism nor -455G/A polymorphism in the beta fibrinogen gene is a genetic marker for @DISEASE$ in Slovene population (Caucasians) with type 2 diabetes.	0
Plasma fibrinogen expression is affected by the beta-fibrinogen gene -455A/G polymorphism, and the @GENE$ allele may be a risk factor for @DISEASE$ in Chinese males.	0
A modest association between @GENE$ and schizophrenia suggests that this gene and the DISC1-mediated molecular pathway might @DISEASE$ in the development of schizophrenia, with FEZ1 affecting only a small subset of Japanese schizophrenia patients.	0
The observation that @GENE$ patients carrying the R allele of FcgammaRIIA are at higher risk of acquiring chronic P. aeruginosa @DISEASE$ suggests that the FcgammaRII loci genetic variation is contributing to this infection susceptibility.	0
This study suggests that FcgammaR @GENE$ a-131 is a major factor predisposing to the development of @DISEASE$ in southern Chinese Han population.	0
We conclude that  Fcgamma receptor polymorphisms influence neither susceptibility nor clinical @DISEASE$ of @GENE$.	0
Thus, we concluded that the association of @GENE$-131H/R and Fc gamma RIIIB-NA1/NA2 polymorphisms with @DISEASE$ in Thailand is not due to the LD caused by Fc gamma RIIIA-176F/V.	0
We conclude that  polymorphisms of the low-affinity Fcgamma receptors are not associated with @DISEASE$ in @GENE$ disease.	0
The @GENE$-R/R131 genotype may be one of the contributors for the increased susceptibility to severe @DISEASE$ in Chinese Han nationality.	0
The present study suggests that the IgG2-binding @GENE$-His/His131 genotype is associated with enhanced susceptibility to PM in @DISEASE$-positive women but not in HIV-negative women.	0
This study provides the first evidence that the infant @GENE$ His/His131 genotype is associated with susceptibility to perinatal HIV-1 @DISEASE$ and further suggests that there is a dose-response relationship for the effect of the Fc gamma RIIa His131 gene on transmission.	0
This is the first evidence for an association between @GENE$ polymorphism and severe @DISEASE$ and provides an example of balancing selective pressures from different infectious diseases operating at the same genetic locus.	0
Although a causative link has not been shown, these data are consistent with an important role for @GENE$ genotype in cardiovascular risk associated with large-artery stiffening and pulse pressure elevation in individuals with @DISEASE$.	0
We did not find any statistically significant association of @DISEASE$ and @GENE$ polymorphisms and haplotypes with AIDS progression.	0
These results are consistent with our initial findings in @DISEASE$ and further support the hypothesis that the @GENE$ and FASL triggered apoptosis pathway plays an important role in human carcinogenesis.	0
On the whole, our data suggest that @DISEASE$ and @GENE$ polymorphisms, as well as their haplotypes, are unlikely to be associated with successful human longevity.	0
In conclusion, our data do not suggest common genetic @GENE$ variants to significantly contribute to the @DISEASE$ of either Hashimoto's thyroiditis or Graves' disease.	0
@DISEASE$-670 polymorphism is not associated with @GENE$ in Chinese patients.	0
A genetic variant in the @DISEASE$ gene is associated with an increased rate of @GENE$ in multifetal pregnancies.	0
Our results do not confirm the hypothesis that @GENE$ genotype in @DISEASE$ gene promoter may be engaged in the development of cervical neoplasia.	0
Our data suggest that the @DISEASE$ promoter -670 polymorphism is associated with development of anti-@GENE$ antibodies in SLE.	0
These findings provide evidence that @GENE$ and PPARgamma work together to influence a biologic pathway affecting @DISEASE$ and body composition, illustrating the importance of investigating the joint effect of genes in determining susceptibility for complex disease.	0
The @GENE$ A54T missense @DISEASE$ may contribute to the TG enrichment of HDL in the postprandial state that, in turn, may alter the risk of atherosclerotic vascular disease.	0
These results therefore suggested that the effects of the @GENE$ polymorphism on TG, LDL-C and body mass index were associated with gender difference and @DISEASE$ amongst non-diabetic Japanese-American subjects.	0
These results suggest that the @GENE$ Thr54 allele may have a @DISEASE$ contribution to the insulin resistance syndrome in a white general population.	0
These results suggest a role for the @GENE$ 385 A/A missense polymorphism as an endocannabinoid risk factor in @DISEASE$/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.	0
Because the Pro129Thr polymorphism reduces enzyme instability, it is unlikely that @DISEASE$ of @GENE$ and enhanced endocannabinoid system induce susceptibility to either methamphetamine dependence/psychosis or schizophrenia.	0
In conclusion, the @GENE$ of FXIII Val34Leu on the venous thromboembolic risk is modest, suggesting that screening for this @DISEASE$ in factor V Leiden carriers is not justified.	0
The 4G/4G-@GENE$ genotype might be a protective factor against ACI, whereas the factor V point @DISEASE$ (1691G-A) and the factor VII Arg/Gln353 gene polymorphism have not proved to be risk factors for ACI.	0
The results suggested that possible association existed between the use of COC and the onset of @DISEASE$, however the mutations of G1691-->A in factor V gene, G20210-->A in @GENE$ gene and I/D polymorphism of ACE gene did not seem to contribute to this association.	0
We conclude that  @GENE$ and the PT-20210A are risk factors for @DISEASE$ as well as Hcy levels, but the MTHFR and PAI-1 polymorphisms do not appear to be associated with VT in our country.	0
These data suggest that @GENE$ is associated with an increased risk of obstetric @DISEASE$, but that the -455A allele of beta-fibrinogen, PGM and MTHFR do not appear to be implicated.	0
Present data indicate that testing for heritable @DISEASE$ would be important to identify aPL subjects with an increased risk of developing @GENE$.	0
Factor @GENE$ gene 3'-UT G20210A @DISEASE$ allele is absent in Chinese patients with ischemic stroke and normal subjects; its mutation may not be a major risk factor for thrombogenesis in Chinese people.	0
The single-nucleotide polymorphism of @GENE$ C807T seems to play a role as a prognostic factor in recovery from sudden @DISEASE$.	0
Homozygosity for @GENE$ 4G or FXIII 34Leu polymorphisms as well as compound carrier status is associated with @DISEASE$ loss.	0
The @GENE$ allele of the amino acid polymorphism of the FXIII gene is associated with a decreased risk of @DISEASE$, and this protecting association seems to be more pronounced in smokers.	0
Our results showed that the FXIII Leu allele has no protective effect in the development of @DISEASE$ in @GENE$.	0
We found @GENE$-fold higher risk of acute @DISEASE$ associated with the homozygosity of the T allele of the F12, 46C-->T polymorphism in the Spanish population.	0
The AluI polymorphism in the ERbeta gene is associated with an increased risk of stage @GENE$ @DISEASE$ in a Japanese population.	0
Polymorphisms in the genes encoding for ERalpha, ERbeta and @GENE$ did not correlate with the occurrence of uterine @DISEASE$ in our Caucasian population.	0
These data thus indicate that the @GENE$ genotype may modulate the relationship between BMD or rates of @DISEASE$ and estrogen levels in men and that bone mass in men with the X or P alleles may be more susceptible to the consequences of estrogen deficiency (and conversely, benefit most from estrogen sufficiency) than in men with the xx or pp genotypes.	0
ER and @GENE$ genes may contribute to @DISEASE$ in a distinct manner: estrogen sensitivity influences the severity in the early phase after menopause while vitamin D plays an important role at older ages when the contribution of estrogen loss is weaker.	0
The results suggest that the studied dinucleotide repeat polymorphism of the @GENE$ gene may contribute to specific components of @DISEASE$.	0
@GENE$ gene RFLPs is related to TCM @DISEASE$ Differentiation typing.	0
Estrogen receptor alpha polymorphisms, but not @GENE$-adrenergic receptor gene, may be associated with a risk of @DISEASE$.	0
Our findings suggest that @GENE$ and ERCC2 SNPs are possible markers for @DISEASE$ formation, whereas cyclin D1 and p16 SNPs may be markers of genes that have an inverse effect on the risk to develop meningioma in irradiated and nonirradiated populations.	0
These results suggest that individuals who smoke and have the @GENE$ codon 312 Asp/Asp genotype may be at a greater risk of p53 mutations, especially if combined with other polymorphisms that may result in @DISEASE$.	0
Adjusting for performance status and @GENE$ of treatment regimen, carrying at least one ERCC1 8092A allele is associated with a >2-fold increase in grade 3 or 4 gastrointestinal toxicity among platinum-treated @DISEASE$ patients.	0
In conclusion, the @GENE$ C8092A polymorphism may be a useful predictor of OS in advanced @DISEASE$ patients treated with platinum-based chemotherapy.	0
Therefore, we suggest that the @GENE$ genotype in codon 118 of ERCC1 is a surrogate marker for predicting better survival in @DISEASE$ patients treated with cisplatin combination chemotherapy.	0
In conclusion, our results support the view that both the @GENE$ codon 594 and HER2 codon 655 polymorphisms are not associated with increased risk of @DISEASE$.	0
These results suggest that sEH and EDHF play some important role in the @DISEASE$ of @GENE$ resistance found in type 2 diabetes.	0
In conclusion, @GENE$ variants at codon 113 and 139 associated with high predicted enzymatic activity appear to increase risk for @DISEASE$, particularly among recent and current smokers.	0
Our data show that the K1019X @DISEASE$ in the @GENE$ gene differs in frequency between AA and EA, is associated with increased risk for PC in AA men with a positive family history, and may be an important genetic risk factor for prostate cancer in AA.	0
In healthy normoglycemic Finnish subjects, the K121Q polymorphism of the @GENE$ gene is associated with @DISEASE$ but not with impaired insulin secretion or dyslipidemia.	0
The results showed that the K121Q @GENE$ polymorphism in the Spanish population has no significant impact on @DISEASE$.	0
We conclude that  carriers of the Q variant of @GENE$ are at increased risk for developing @DISEASE$ early in the course of type 1 diabetes.	0
We conclude that  the interaction between the K121Q polymorphism of the @GENE$ gene and birth length affects @DISEASE$ and increases susceptibility to type 2 diabetes and hypertension in adulthood.	0
In conclusion, we have identified a possible molecular mechanism for @GENE$ overexpression that confers an increased risk for @DISEASE$-related abnormalities.	0
In summary, the HPC2 gene variants Leu217 and Thr541 were associated with an increased risk for @DISEASE$ and for @GENE$ in males undergoing radical prostatectomies in the Calgary region.	0
The @DISEASE$ of @GENE$ mutations and lack of association between polymorphisms in ELAC2 and prostate cancer in cases and controls leads us to conclude that ELAC2 does not contribute significantly to the elevated prevalence of prostate cancer in Afro-Caribbean males of Tobago.	0
Therefore, @GENE$ and RNASEL may play a role in prostate @DISEASE$ and severity.	0
There is no evidence that either @GENE$ polymorphism is associated with prostate cancer or @DISEASE$ level.	0
This study suggests that epithelium-specific @GENE$ and ETS-3 genes are unlikely to contain polymorphic loci that have a major impact on @DISEASE$ susceptibility in our population.	0
@GENE$ @DISEASE$ and EGFR amplification are important prognostic factors in patients with anaplastic astrocytoma and in older patients with glioblastoma multiforme, respectively.	0
These results indicate that @DISEASE$ is not associated with AluI polymorphism of @GENE$ gene and EGF gene polymorphism is different between schizophrenia and lung cancer patients.	0
Our findings suggest that the A-G polymorphism of @GENE$ is involved not only in the occurrence but also in the malignant @DISEASE$ of gastric cancer.	0
In summary, in our group, the @GENE$ +61 polymorphism was not a risk factor for CMM susceptibility, but this polymorphism may play a role in @DISEASE$.	0
Our study thus suggests possible involvement of @GENE$ in essential @DISEASE$.	0
Although a functional relevance of the @GENE$ G-N haplotype itself remains unclear, the data demonstrate that genetic variation at the EDN1 locus has a significant effect on @DISEASE$ filtration but not on UAE in the general	0
Our @DISEASE$ suggests a gender-specific relationship between the G5665T @GENE$ polymorphism and change in SBP in response to antihypertensive treatment with irbesartan or atenolol, suggesting the endothelin pathway to be a common mechanism included in the hypertensive action of the drugs.	0
All our results indicate that the presence of the @GENE$ genotype (++) in patients with structural @DISEASE$, severe left ventricular dysfunction and malignant ventricular arrhythmias increases the risk for these patients of hemodynamic collapse during these arrhythmias.	0
It follows that the examined polymorphisms in the genes for @GENE$, angiotensinogen, and ET-1 could participate in the etiopathogenesis of @DISEASE$ diseases.	0
All our results suggested that the presence of the (++)@GENE$ genotype in patients with structural @DISEASE$, severe left ventricular dysfunction, and malignant ventricular arrhythmia put these patients at a higher risk of hemodynamic collapse during arrhythmic episodes.	0
Herewith, we report, based on a case-control analysis, that the same @GENE$ polymorphism participates in susceptibility to the endemic form of PF seen in Tunisia and, thus, show that common genetic factors govern the breakage of @DISEASE$ to desmoglein 1 in different epidemiological and environmental situations.	0
We conclude that  the DRP-2 *2236 C allele may @GENE$ another polymorphism in DRP-2, or in a nearby gene, that may influence susceptibility to @DISEASE$.	0
Our results suggest that the *2236C allele in the 3'@GENE$ of the DRP-2 gene, or an unknown @DISEASE$ in linkage disequilibrium with this allele, may reduce the susceptibility to schizophrenia, especially the paranoid subtype.	0
The present study did not provide any evidence for a contribution of the @GENE$ gene to susceptibility to @DISEASE$.	0
These results suggest that the *2236C allele in the 3'@GENE$ of the DRP-2 gene, or an unknown @DISEASE$ in linkage disequilibrium with this allele, may reduce the susceptibility to schizophrenia, especially the paranoid subtype.	0
These results provide further evidence of an association between @GENE$ and cervical dystonia, supporting the involvement of the dopamine pathway in the @DISEASE$ of CD.	0
No evidence for an involvement of @GENE$, DRD5, HLA-DRB, or polymorphisms in the homocysteine pathway in the @DISEASE$ of F-ITD was found.	0
No significant difference was demonstrated for genotype or allele frequency when comparing @GENE$-dependent and control cases for the DRD2 TaqI and the DRD4 gene exon III VNTR polymorphisms, suggesting that these two polymorphisms do not play major roles in MAP @DISEASE$ for our sample of Chinese males.	0
Thus, an interaction between @GENE$ and 5-HTTLPR genes constitutes susceptibility to @DISEASE$, thereby yielding apparent relationships between the major psychiatric symptomatology scores and genotype combinations in samples that are obtained by pooling schizophrenia with other diagnostic categories.	0
Using these methods, no association was found between the -616 C/G SNP and @DISEASE$ factors of Cloninger's temperament and character inventory (@GENE$) in our population.	0
In children with ADHD, possession of the @GENE$ 7-repeat allele appears to be associated with an inaccurate, impulsive response style on neuropsychological tasks that is not explained by ADHD @DISEASE$ severity.	0
Results suggested that @GENE$ L participants demonstrated significantly higher craving after @DISEASE$ of alcohol as compared with the control beverage.	0
The @GENE$ gene is probably not of importance to the different @DISEASE$ dimensions as measured by the Karolinska Scales of Personality.	0
Overall our results indicates that the HTR2A, @GENE$, DRD3 and GABA(A)gamma2 genes are not likely to be a major genetic risk factor for @DISEASE$ in this population, with the exception of possible association between nasal inhalation and DRD2 promoter - 141DeltaC polymorphism.	0
We conclude that  the investigated @GENE$ polymorphism does not have a major impact on @DISEASE$ in the investigated population.	0
We found no evidence that the @GENE$ gene is likely to confer susceptibility to the development of @DISEASE$ in Chinese patients with schizophrenia.	0
Our results possibly indicate an association of @DISEASE$ with @GENE$ homozygosity (P=0.056).	0
These data suggest that the @GENE$ Ser9Gly polymorphism or, alternatively, another genetic variation that is in linkage disequilibrium, may influence response to risperidone in negative @DISEASE$ and social functioning.	0
These results do not provide evidence for an involvement of the @GENE$ gene in @DISEASE$ pressure levels or in the pathogenesis of diabetic nephropathy in type 1 diabetic patients.	0
The results of our study suggest that variations of the @GENE$ gene are likely involved in the regulation of impulsivity and some psychopathological aspects of @DISEASE$ related to violent behavior.	0
These results are consistent with no role for genetic variation of the @GENE$ dopamine receptor in susceptibility to @DISEASE$.	0
In conclusion, we suggest that Gly/Gly homozygotes in the MscI polymorphic site of the @GENE$ gene may cause some change in the function of the dopamine D3 receptor and may be involved the @DISEASE$ of TD.	0
We conclude that  this @GENE$ polymorphism is not a risk factor for @DISEASE$ in our sample.	0
Although there remains a possibility that the @GENE$ TaqI A polymorphism plays some role in modifying the phenotype of the @DISEASE$, these results suggest that neither the A1 allele nor the homozygous A1 genotype is associated with alcoholism.	0
Our results provide evidence for a possible developmental link between @GENE$ and @DISEASE$ via early sustained attention and information processing.	0
Our findings indicate that the @GENE$ -141C @DISEASE$ allele and the 5-HTTLPR S allele are genetic risk factors for alcoholism in Mexican-Americans, and that smoking modulates the association between genetic risk factors and alcoholism.	0
These findings suggest that @GENE$ TaqIA polymorphism may be associated with an increased risk for developing motor @DISEASE$ in PD.	0
No association was found between TaqI A @GENE$ polymorphism and @DISEASE$ in the Russians and the Tatars.	0
In the @GENE$ of this @DISEASE$, A2A2 DRD2 genotype appears to be related to chronicity of schizophrenia.	0
We conclude that @GENE$ alleles are not associated with @DISEASE$ in this sample, and that genetic variation at the DRD2 locus is not likely to be an important contributor to risk for this disorder.	0
We conclude that  our data do not support an allelic association between the @GENE$ allele at DRD2 and @DISEASE$.	0
This result indicates that germline mutations in @GENE$ are unlikely to cause an inherited predisposition to @DISEASE$.	0
The markedly increased bone density in individuals having the @GENE$, 4 bp DEL,NT3198 @DISEASE$ shows that this alteration affects both endochondral and intramembranous bone formation and suggests that the DLX3 gene is important in bone formation and/or homeostasis of the appendicular skeleton.	0
The AT/@GENE$ genotype of DLST gene is associated with an increased risk for @DISEASE$.	0
The DLD genotype appears to operate independently of @GENE$ in conferring @DISEASE$ risk.	0
These data support the idea that these apparently distinct @DISEASE$ have at least a partially convergent etiology and that variation at the @GENE$ locus predisposes individuals to a variety of psychiatric disorders.	0
The DII-ORFa-Gly3Asp and DII-Thr92Ala polymorphisms do not explain differences in well-being, neurocognitive functioning, or appreciation of T4/@GENE$ combination therapy in patients treated for @DISEASE$.	0
These results indicate that genetic variations in the @GENE$ gene encoding hBD-1 may have a major role in mediating and/or contributing to susceptibility to @DISEASE$.	0
The @GENE$ SNPs examined are not involved in susceptibility to juvenile @DISEASE$.	0
Thus, our results do not support an involvement of the 1-bp or 4-bp @DISEASE$ within the @GENE$ gene in the etiology of affective disorders.	0
The 179 allele variant of the @GENE$ gene is related to a slower @DISEASE$ of DN in type 1 diabetic patients with albuminuria and receiving antihypertensive therapy.	0
In a selected Caucasian population, the DAZL SNP 386 is completely absent and SNP 260 is not associated with @GENE$ and therefore does not represent a molecular marker for genetic diagnosis of @DISEASE$.	0
These results indicated that specific variants of the @GENE$ gene might be associated with the mechanisms responsible for adult BA and contribute to airway @DISEASE$ and remodeling.	0
In the haplotype analysis based on the information of linkage-disequilibrium @DISEASE$ across this gene locus, we demonstrated a highly significant association between schizophrenia and a @GENE$ haplotype (P = 2.0173 x 10(-21)), which therefore provides an independent statistical support for association of the DAAO gene with schizophrenia and indicates that the DAAO gene may play a significant role in the etiology of schizophrenia in the Han Chinese.	0
In conclusion, we present evidence that the CC variant of the A-278C polymorphism in the rate-limiting enzyme in the catabolism of cholesterol, @GENE$, increases the @DISEASE$ of atherosclerosis and possibly the risk of a new clinical event.	0
A decreased risk of proximal @DISEASE$ in relation to the CC genotype of @GENE$ A-203C, which probably renders less activity of the enzyme converting cholesterol to bile acids, is new evidence for the role of bile acids in colorectal carcinogenesis.	0
Here we report that polymorphisms within the APOE promoter, ACE1 and CYP46 gene are not risk factors for @DISEASE$ and are not associated with parenchymal or vascular accumulation of @GENE$.	0
Our results provide an important independent replication of previous findings, supporting the existence of @GENE$ sequence variants that contribute to variability in beta-@DISEASE$ metabolism.	0
Our results indicate that the intron 2 CYP46 @GENE$ genotype may predispose to @DISEASE$, and this association is independent of the apolipoprotein E genotype.	0
These findings provide direct evidence that @GENE$ and ApoE polymorphisms synergically increase the risk for AD development, and influence on the rate of @DISEASE$.	0
@GENE$ influences brain beta-@DISEASE$ load, cerebrospinal fluid levels of beta-amyloid peptides and phosphorylated tau, and the genetic risk of late-onset sporadic AD.	0
Despite growing evidence implicating cholesterol metabolism in @DISEASE$ risk and @GENE$ generation, our data does not support a robust genetic relationship between the CYP46 intron 2 polymorphism and AD risk or neuropathology.	0
The observation that @GENE$ and CYP3A43 were associated with prostate cancer, are not in linkage equilibrium, and are both involved in testosterone metabolism, suggest that both CYP3A4*1B and CYP3A43*3 may influence the probability of having prostate cancer and @DISEASE$ severity.	0
The @GENE$*6 allele is rare in the Caucasian population, and no association is inferred between this allelic variant and @DISEASE$.	0
Polymorphic variants of @GENE$ genes may contribute to the @DISEASE$ of liver disease and HCC risk in HCV-infected subjects.	0
In conclusion, genetic polymorphisms of @GENE$ 2D6 and 2E1, PXR, and MDR1 do not appear to play a role in the onset of @DISEASE$.	0
Therefore, no significant association between @GENE$ RsaI, CYP2E1 DraI, ADH1C, NQO1 polymorphisms and alcohol @DISEASE$ was observed in healthy controls.	0
The @GENE$ C2 allele is a susceptibility factor for colorectal cancer, especially for @DISEASE$, and there is an apparent gene-environment interaction between the susceptible genotype and salted food.	0
The CYP2E1 @GENE$/c1 genotype is a susceptibility factor for development of @DISEASE$ in Chinese and there is an apparent gene-environment interaction between the susceptible genotype and cigarette smoking.	0
This result suggests that susceptibility to @DISEASE$ may be associated with the RsaI and @GENE$ polymorphism of the P450IIE1 gene.	0
